% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • biobottom biobottom Aug 6, 2012 1:37 PM Flag

    This smells like a bear raid

    You know, I've owned this company since the 90's. It is the only stock I have recommended to friends and family.

    I feel betrayed by Junius. I think it is unwise to lie to shareholders. "Plenty of money, blah, blah blah." "No need to raise more capital..."

    So are we supposed to believe you now Junius? How much do you pay yourself? I hope you have some stock you purchased with real money like us retail suckers, so you can share our pain.

    BTW, what incompetent negotiated that royalty rate?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • if you were a long time shareholder you would know the royalty rate was negotiated many years ago before the technology was proven and you would also know the current CEO had nothing to do with the negotiation. Dan did not lie to the shareholders, but he could have handled the questions better since this was not new information. This (IMO) was a planned attack aided by the analysts on the call. Shorts win because they were in major pain, institutions that wanted in at a lower price are happy, only the long term owners lose. Time will tell, but I say this opportunity is similar to the $5 stock available after the Roche FDA T-DM1 turn down.

      • 1 Reply to bioimmunomabman
      • Bioimmune, we are on the same side and I appreciate your posts. I think it was misleading for Junius to proclaim that they were flush with funds, like on Cramer, then dilute us, even if they got a good price for the shares. I know the royalty rate is pre-Junius, but Mitch was a straight shooter. My point was that the CEO has an obligation, even to us retail nobodies, to be straightfoward. Its great to promote the stock, but should be done with vision, not deception.

10.65-0.19(-1.75%)1:51 PMEDT